Table of Contents
Metal-Based Drugs
Volume 2009, Article ID 420784, 8 pages
http://dx.doi.org/10.1155/2009/420784
Research Article

Synthesis, Structure, Electrochemistry, and Cytotoxic Properties of Ferrocenyl Ester Derivatives

1Department of Chemistry, University of Puerto Rico, P.O. Box 9019, Mayagüez, PR 00681, USA
2Department of Pharmacology, Toxicology and Physiology, Ponce School of Medicine, P.O. Box 7004, Ponce, PR 00732, USA

Received 22 November 2008; Accepted 26 January 2009

Academic Editor: Roger Alberto

Copyright © 2009 Li Ming Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Kealy and P. L. Pauson, “A new type of organo-iron compound,” Nature, vol. 168, no. 4285, pp. 1039–1040, 1951. View at Publisher · View at Google Scholar
  2. S. A. Miller, J. A. Tebboth, and J. F. Tremaine, “Dicyclopentadienyliron,” Journal of the Chemical Society, pp. 632–635, 1952. View at Publisher · View at Google Scholar
  3. A. Togni and T. Hayashi, Eds., Ferrocenes: Homogeneous Catalysis/Organic Synthesis/Materials Science, A. Togni and T. Hayashi, Eds., Wiley-VCH, Weinheim, Germany, 1995.
  4. R. Gómez Arrayás, J. Adrio, and J. C. Carretero, “Recent applications of chiral ferrocene ligands in asymmetric catalysis,” Angewandte Chemie—International Edition, vol. 45, no. 46, pp. 7674–7715, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. A. Togni and R. L. Halterman, Eds., Metallocenes, A. Togni and R. L. Halterman, Eds., Wiley-VCH, Weinheim, Germany, 1998.
  6. R. C. J. Atkinson, V. C. Gibson, and N. J. Long, “The syntheses and catalytic applications of unsymmetrical ferrocene ligands,” Chemical Society Reviews, vol. 33, no. 5, pp. 313–328, 2004. View at Publisher · View at Google Scholar · View at PubMed
  7. H. Köpf and P. Köpf-Maier, “Titanocene dichloride—the first metallocene with cancerostatic activity,” Angewandte Chemie—International Edition in English, vol. 18, no. 6, pp. 477–478, 1979. View at Publisher · View at Google Scholar · View at PubMed
  8. G. Jaouen, Ed., Bioorganometallics, G. Jaouen, Ed., Wiley-VCH, Weinheim, Germany, 2006.
  9. P. Köpf-Maier, H. Köpf, and E. W. Neuse, “Ferricenium complexes: a new type of water-soluble antitumor agent,” Journal of Cancer Research and Clinical Oncology, vol. 108, no. 3, pp. 336–340, 1984. View at Publisher · View at Google Scholar
  10. D. R. van Staveren and N. Metzler-Nolte, “Bioorganometallic chemistry of ferrocene,” Chemical Reviews, vol. 104, no. 12, pp. 5931–5985, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. M. F. R. Fouda, M. M. Abd-EIzaher, R. A. Abdelsamaia, and A. A. Labib, “On the medicinal chemistry of ferrocene,” Applied Organometallic Chemistry, vol. 21, no. 8, pp. 613–625, 2007. View at Publisher · View at Google Scholar
  12. G. Tabbì, C. Cassino, G. Cavigiolio et al., “Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process,” Journal of Medicinal Chemistry, vol. 45, no. 26, pp. 5786–5796, 2002. View at Publisher · View at Google Scholar
  13. D. Osella, H. Mahboobi, D. Colangelo, G. Cavigiolio, A. Vessières, and G. Jaouen, “FACS analysis of oxidative stress induced on tumour cells by SERMs,” Inorganica Chimica Acta, vol. 358, no. 6, pp. 1993–1998, 2005. View at Publisher · View at Google Scholar
  14. H. Tamura and M. Miwa, “DNA cleaving activity and cytotoxic activity of ferricenium cations,” Chemistry Letters, vol. 26, no. 11, pp. 1177–1178, 1997. View at Publisher · View at Google Scholar
  15. R. Kovjazin, T. Eldar, M. Patya, A. Vanichkin, H. M. Lander, and A. Novogrodsky, “Ferrocene-induced lymphocyte activation and anti-tumor activity is mediated by redox-sensitive signaling,” The FASEB Journal, vol. 17, no. 3, pp. 467–469, 2003. View at Publisher · View at Google Scholar · View at PubMed
  16. T. W. Spradau and J. A. Katzenellenbogen, “Preparation of cyclopentadienyltricarbonylrhenium complexes using a double ligand-transfer reaction,” Organometallics, vol. 17, no. 10, pp. 2009–2017, 1998. View at Publisher · View at Google Scholar
  17. L. Busetto, M. C. Cassani, V. G. Albano, and P. Sabatino, “Coordination chemistry of ester-functionalized Cp ligands. The atom-economy synthesis of Na[C5H4CO2(CH2)2OH], solid state structures of [Rh{C5H4CO2(CH2)2OH}(CO)2] and [Rh2{μ-(C5H4CO2CH2)2}(NBD)2],” Organometallics, vol. 21, no. 9, pp. 1849–1855, 2002. View at Publisher · View at Google Scholar
  18. B. F. Bonini, M. Fochi, L. Lunazzi, and A. Mazzanti, “Conformational studies by dynamic NMR. 72. Stereolabile enantiomers of acyl and thioacyl ferrocenes,” Journal of Organic Chemistry, vol. 65, no. 8, pp. 2596–2598, 2000. View at Publisher · View at Google Scholar
  19. L. M. Gao, R. Hernández, J. Matta, and E. Meléndez, “Synthesis, Ti(IV) intake by apotransferrin and cytotoxic properties of functionalized titanocene dichlorides,” Journal of Biological Inorganic Chemistry, vol. 12, no. 7, pp. 959–967, 2007. View at Publisher · View at Google Scholar · View at PubMed
  20. J. D. Dunitz, L. E. Orgel, and A. Rich, “The crystal structure of ferrocene,” Acta Crystallographica, vol. 9, part 4, pp. 373–375, 1956. View at Publisher · View at Google Scholar
  21. L. Pauling, The Nature of the Chemical Bond, Cornell University Press, Ithaca, NY, USA, 3rd edition, 1960.
  22. M. Cetina, M. Jukić, V. Rapić, and A. Golobič, “Ferrocene compounds. XXXVIII. Di-methyl ferrocene-1,1-dicarboxylate,” Acta Crystallographica Section C, vol. 59, no. 6, pp. m212–m214, 2003. View at Publisher · View at Google Scholar
  23. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar
  24. F. Denizot and R. Lang, “Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability,” Journal of Immunological Methods, vol. 89, no. 2, pp. 271–277, 1986. View at Publisher · View at Google Scholar
  25. P. James, J. Neudörfl, M. Eissmann, P. Jesse, A. Prokop, and H.-G. Schmalz, “Enantioselective synthesis of ferrocenyl nucleoside analogues with apoptosis-inducing activity,” Organic Letters, vol. 8, no. 13, pp. 2763–2766, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. A. Vessières, S. Top, P. Pigeon et al., “Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro,” Journal of Medicinal Chemistry, vol. 48, no. 12, pp. 3937–3940, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. C. L. Ferreira, C. B. Ewart, C. A. Barta et al., “Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates,” Inorganic Chemistry, vol. 45, no. 20, pp. 8414–8422, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. G. Caldwell, M. G. Meirim, E. W. Neuse, and C. E. J. van Rensburg, “Antineoplastic activity of polyaspartamide-ferrocene conjugates,” Applied Organometallic Chemistry, vol. 12, no. 12, pp. 793–799, 1998. View at Publisher · View at Google Scholar
  29. A. J. Corey, N. O'Donovan, Á. Mooney, D. O'Sullivan, D. K. Rai, and P. T. M. Kenny, “Synthesis, structural characterization, in vitro anti-proliferative effect and cell cycle analysis of N-(ferrocenyl)benzoyl dipeptide esters,” Journal of Organometallic Chemistry. In press. View at Publisher · View at Google Scholar